Upon the treatment with VEGF pathway inhibitors, primary brain tumors as well as brain metastases can switch from the angiogenic to the cooptive growth and by that evade the anti-angiogenic therapy [24,40,41,42]. Here, VEGFA is linked to brain neoplasm.